- Atlas
- Natural Sciences
- Chemical Biology
Chemical Biology
Chemical biology is the branch of chemistry that uses chemical tools and ideas to study, and often to control, living systems.
10 frameworks, from 1800 to today · Chemistry · Natural Sciences
- Natural products chemistry 1800-1990
- Molecular pharmacology 1900-Present
- Chemical genetics 1990-Present
- Fluorescent protein tagging 1994-Present
- DNA-encoded chemical library 1995-Present
- Activity-based proteomics 1997-Present
- Bioorthogonal chemistry 2000-Present
- Chemoproteomics 2000-Present
- Optogenetics 2005-Present
- Photopharmacology 2005-Present
Overview
Chemical biology is the branch of chemistry that uses chemical tools and ideas to study, and often to control, living systems1. Its practitioners ask not only what molecules are inside a cell but how to make molecules that will report on, switch on, or switch off particular biological processes1. What is at stake is a kind of molecular engineering of life: probes that light up a protein only when it is active, drugs that can be turned on with a pulse of light, and libraries of millions of compounds screened inside a test tube. The field sits between organic chemistry, which supplies the synthetic skill, and biology, which supplies the problem1.
From Natural Products to Molecular Pharmacology
For most of the nineteenth and early twentieth centuries, the chemistry of living things was the chemistry of natural products. Chemists isolated alkaloids such as morphine from opium poppy, quinine from cinchona bark, and later penicillin from mould, and worked out their structures by degradation and synthesis. This tradition gave medicine its first pure drugs and taught chemists that nature produces molecules of extraordinary complexity and biological potency. The isolation and structural elucidation of natural products remained a central activity well into the twentieth century, and total synthesis—building such a molecule from simple starting materials—became a proving ground for organic method.
A parallel strand came from pharmacology. In the early twentieth century, Paul Ehrlich's work on arsenical drugs for syphilis and his concept of the "magic bullet"—a compound that would hit a disease organism and not the patient—established the idea that a drug acts at a specific molecular target. Later, the receptor concept, developed by John Newport Langley and others around the turn of the century, proposed that drugs bind to particular sites on cells2. Molecular pharmacology grew from this: the study of how a compound's structure determines its binding to a protein and its effect on the organism. By the mid-twentieth century, chemists and pharmacologists were routinely asking how a small molecule interacts with a biological macromolecule, and the language of structure–activity relationships became standard.
The Rise of Chemical Genetics and Molecular Probes
A decisive shift came in the 1990s, when the completion of genome sequencing projects made it possible to think about biology one gene and one protein at a time. Chemical genetics emerged as the deliberate use of small molecules to perturb proteins in living cells, analogous to the way geneticists use mutations3. The logic was simple: if a mutation can reveal what a gene does, a small molecule that inhibits or activates its protein product can do the same, and often more reversibly and with finer control over timing. A classic demonstration was the use of small molecules to probe cell-cycle regulation; researchers could add a compound and watch a process stop within minutes, something genetic knockouts could not easily achieve.
This period also saw the refinement of fluorescent protein tagging. The green fluorescent protein (GFP), isolated from the jellyfish Aequorea victoria, was cloned and shown to fluoresce in other organisms in the early 1990s, work that led to the 2008 Nobel Prize in Chemistry for Osamu Shimomura, Martin Chalfie, and Roger Tsien. By fusing GFP to a protein of interest, researchers could watch that protein's location and movements in a living cell1. Tsien's laboratory later engineered variants in many colours, making it possible to follow several proteins at once. Fluorescent tagging turned the cell into a stage on which molecular actors could be watched in real time.
Activity-Based Profiling and Chemical Proteomics
A limitation of many inhibitors is that they bind a protein whether or not it is active. Activity-based protein profiling (ABPP), developed in the late 1990s and 2000s, addressed this by designing probes that react only with the active form of an enzyme4. The probe typically carries a reactive group that covalently modifies the enzyme's active-site residue, plus a tag—a fluorophore or biotin—for detection. Because the probe competes with the enzyme's natural substrate, it reports on activity rather than mere presence. ABPP made it possible to compare which enzymes are active in healthy versus diseased tissue, and to identify the targets of drugs in complex proteomes4.
Chemical proteomics extended this logic to the whole proteome5. By using broad-spectrum probes or drug-derived affinity reagents, researchers could pull down and identify hundreds of proteins at once, asking which ones a given compound engages in a living cell. This was a significant change from the earlier habit of studying one purified enzyme at a time. It also exposed the promiscuity of many drugs, showing that a compound thought to hit one target might bind several others5.
Bioorthogonal Chemistry
A persistent problem in labelling biomolecules inside cells is that the label itself must not react with the thousands of other reactive groups present1. Bioorthogonal chemistry, developed largely from the late 1990s onward, solved this by creating pairs of functional groups that react with each other rapidly and selectively while ignoring everything else in the cell. The Staudinger ligation, reported by Carolyn Bertozzi and colleagues in 2000, allowed an azide-labelled molecule to be attached to a phosphine-bearing probe. Later, the copper-free click reaction between azides and strained cyclooctynes, developed in the 2000s, gave a faster and more biocompatible coupling. These reactions let researchers tag glycans, proteins, and lipids in living systems without disrupting normal chemistry6. Bioorthogonal chemistry became a general enabling method, and its developers were recognized with the 2022 Nobel Prize in Chemistry67.
Optogenetics and Photopharmacology
The ability to control biological processes with light took two related forms. Optogenetics, developed in the 2000s, uses genetically encoded light-sensitive proteins—channelrhodopsins and related microbial opsins—to make specific neurons fire or fall silent when illuminated. The technique, pioneered in the laboratory of Karl Deisseroth and others, gave neuroscience a tool for turning circuits on and off with millisecond precision. It is a genetic method at heart, but its reliance on light-sensitive proteins and on chemical understanding of retinal-based chromophores places it close to chemical biology.
Photopharmacology takes a different route: it attaches a light-sensitive chemical switch—often an azobenzene group that changes shape when illuminated—to a drug molecule8. The compound is inactive until light of one wavelength converts it to its active form; light of another wavelength turns it off. This allows drug action to be confined to a chosen place and time, reducing systemic side effects8. The approach was developed in the 2000s and 2010s, with early demonstrations on ion channels and receptors. Both optogenetics and photopharmacology share the goal of precise spatial and temporal control, one through genetic engineering and the other through chemistry.
DNA-Encoded Libraries
Screening large numbers of compounds for binding to a protein target has always been limited by the physical quantity of material that can be handled. DNA-encoded libraries, developed from the 1990s onward, solved this by attaching a unique DNA sequence to each compound in a library, so that the identity of a hit can be read out by sequencing. Millions to billions of compounds can be pooled and screened in a single tube; the DNA tag acts as a barcode. The approach required advances in DNA-compatible chemistry, since many standard reactions damage DNA9. By the 2010s, DNA-encoded libraries had become a standard tool in drug discovery, used by both academic groups and pharmaceutical companies to find starting points for new medicines.
The Present
Chemical biology today is a broad, method-driven field. Fluorescent proteins and bioorthogonal labels are routine tools in cell biology. Activity-based probes and chemical proteomics are used to map enzyme activity and drug targets across proteomes4. Optogenetics and photopharmacology continue to expand the range of biological processes that can be controlled with light108. DNA-encoded libraries and other high-throughput screening methods feed medicinal chemistry9. The field's open questions are practical and fundamental: how to make probes that are truly specific in the crowded environment of a cell, how to deliver light deep into tissue, how to design compounds that engage difficult targets such as protein–protein interactions, and how to predict which chemical tool will perturb a biological system in the way intended. The history of chemical biology is the history of learning to speak to living systems in their own chemical language—and of building the vocabulary one probe at a time.
References
- Chemical biology (introduction, Biological fluorescence, Bioorthogonal reactions), Wikipedia
- Receptor theory, Wikipedia
- Chemical genetics, Wikipedia
- Activity-based proteomics (introduction, Historical development), Wikipedia
- Chemoproteomics, Wikipedia
- Bioorthogonal chemistry, Wikipedia
- Click chemistry (History), Wikipedia
- Photopharmacology, Wikipedia
- DNA-encoded chemical library (History, introduction), Wikipedia
- Optogenetics, Wikipedia
The frameworks of Chemical Biology
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1800-1990
- 1900-Present
- 1990-Present
- 1994-Present
- 1995-Present
- 1997-Present
- 2000-Present
- 2000-Present
- 2005-Present
- 2005-Present

Chemical Biology is a planet in Nousfarer
Its city has a tower for each of these 10 frameworks. Land, walk in, and climb one concept at a time.
Land on Chemical BiologyRelated fields
More in Chemistry
- Analytical Chemistry
- Catalysis
- Chemical Kinetics
- Chemistry
- Computational Chemistry
- Electrochemistry
- Green Chemistry
- Inorganic Chemistry
- Materials Chemistry
- Medicinal Chemistry
- Nuclear Chemistry
- Organic Chemistry
- Organometallic Chemistry
- Physical Chemistry
- Spectroscopy
- Supramolecular Chemistry
- Surface Chemistry
- Theoretical Chemistry
See where Chemical Biology sits on the Map of Human Knowledge